Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry|February 1, 2025
Discovery of novel spirocyclic derivates as potent androgen receptor antagonistsWenqiang Zhang, Xiaoyu Zhou, Hao Zhu, et al.BMC Medicine|August 12, 2024
Influences of HPV disease perceptions, vaccine accessibility, and information exposure on social media on HPV vaccination uptake among 11,678 mothers with daughters aged 9-17 years in China: a cross-sectional studyZian Lin, Siyu Chen, Lixian Su, et al.Bioorganic Chemistry|May 16, 2024
Discovery of novel biphenyl derivatives as androgen receptor degraders for the treatment of enzalutamide-resistant prostate cancerWenqiang Zhang, Yawen Fan, Yan Zhang, et al.Journal of Medicinal Chemistry|July 8, 2026
Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic AlopeciaYan Zhang, Wenqiang Zhang, Feng Tang, et al.Small (Weinheim an Der Bergstrasse, Germany)|July 21, 2025
Hydrogel Microspheres Empowering Organ-on-a-Chip Systems: Innovations and ApplicationsJiacheng Liu, Chengcheng Du, Jinping Chen, et al.Nature Communications|August 12, 2025
From fish to fiber: 3D-nanoprinted optical neuromast for multi-integrated underwater detectionLiangye Li, Xuhao Fan, Geng Chen, et al.Human Genetics|March 25, 2023
Biallelic CLCN2 mutations cause retinal degeneration by impairing retinal pigment epithelium phagocytosis and chloride channel functionPing Xu, Zhuolin Chen, Jianchi Ma, et al.Journal of Medicinal Chemistry|April 15, 2025
Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate CancerWenqiang Zhang, Hao Zhu, Zhuolin Chen, et al.Journal of Medicinal Chemistry|December 21, 2023
Discovery of (2<i>S</i>)-<i>N</i>-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia TreatmentWenqiang Zhang, Siqi Zhao, Yi Luo, et al.JAMA Neurology|May 26, 2026
Effect of Electroacupuncture on Postherpetic Neuralgia: A Randomized Clinical TrialLu Chen, Qianyan Liu, Lixia Pei, et al.Pageof 4